MediBang Inc.

Is MediBang a subsidiary of another company?
No. MediBang Inc. is an independent private company founded by Hideyuki Takashima in 2014. It is not part of any larger group, though it maintains partnerships including the Jump Paint collaboration with manga publisher Shueisha.

Is MediBang publicly traded?
No. MediBang Inc. is a private Japanese company with no stock listing, owned by its founder and private investors. It operates from Shibuya, Tokyo with approximately 49 employees.

When was MediBang founded?
MediBang Inc. was founded on January 27, 2014, by Hideyuki Takashima in Tokyo, launching MediBang Paint the same year as a free illustration and manga creation application.

Who founded MediBang?
Hideyuki Takashima founded the company and leads it as its principal executive, building the MediBang Paint software and the surrounding ART street creator ecosystem.

What is MediBang's market position?
MediBang is the leading free digital art application for illustration and manga creation, serving beginners and aspiring artists with an integrated content platform. It competes with Procreate, Clip Studio Paint, and Sketchbook primarily on price accessibility.

Is MediBang Paint really free?
The core MediBang Paint software is free across all platforms, monetized through an optional Premium subscription adding features and cloud storage, plus revenue from the broader MediBang ecosystem services including the ART street platform.

Hideyuki Takashima founded MediBang Inc. in January 2014 in Tokyo, launching MediBang Paint that year as a free illustration and comic creation application. The free model differentiated it immediately from paid competitors, targeting the large market of aspiring artists and manga creators who could not afford professional tools.

The company expanded the ecosystem around the software: ART street launched as a social platform for sharing artwork, the Jump Paint collaboration with Shueisha provided tools tied to aspiring manga publication pipelines, and cloud services connected user files across devices.

Through the 2020s MediBang Paint has maintained continuous development across all platforms, adding features and brush options while retaining its free core, monetizing through optional premium subscriptions and platform services. The product has grown particularly strongly in Japan and Asian markets.

As a software company MediBang's footprint is digital. Its primary social contribution is democratizing creative tools: free professional-capable software lowers the barrier for aspiring artists globally, particularly in markets where paid alternatives are inaccessible.

MediBang maintains a clean record with no significant controversies on file. Standard software industry considerations around cloud service privacy and user content policies apply at its scale.